MiNK Therapeutics, Inc. (INKT) Stock Ticker
Market factors today
Unlock the full INKT picture
About MiNK Therapeutics, Inc.
MiNK Therapeutics, Inc. is a biopharmaceutical firm currently undergoing clinical trials. Its primary focus is on the identification, advancement, and market introduction of innovative invariant natural killer T (iNKT) cell therapies. These treatments are allogeneic and designed to be "off-the-shelf," providing readily available options for combating various cancers and conditions rooted in immune system dysfunction. The company's leading investigational therapy is AGENT-797. This product is an allogeneic, ready-to-use iNKT cell therapy, presently in Phase 1 clinical studies to assess its effectiveness against different forms of myeloma. Established in 2017, the company was previously known as AgenTus Therapeutics, Inc. MiNK Therapeutics, Inc. is headquartered in New York, New York, and operates as a subsidiary of Agenus Inc.
INKT stock facts
| Ticker symbol | INKT |
| Exchange | NASDAQ Capital Market |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market cap | $60.7M |
| CEO | Jennifer S. Buell |
| Employees | 15 |
| Headquarters | New York City, NY, US |
| IPO date | 2021-10-15 |
| Website | minktherapeutics.com |
What you can see for INKT on Tickr
Live INKT price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the INKT report.
Rankings
FAQ
What is the ticker symbol for MiNK Therapeutics, Inc.?
The ticker symbol for MiNK Therapeutics, Inc. is INKT, listed on the NASDAQ Capital Market.
What is INKT?
MiNK Therapeutics, Inc. is a biopharmaceutical firm currently undergoing clinical trials. Its primary focus is on the identification, advancement, and market introduction of innovative invariant natural killer T (iNKT) cell therapies. These treatments are allogeneic and designed to be "off-the-shelf," providing readily available options for combating various cancers and conditions rooted in…